Omaha Healthcare Company Recognized for Brand Launch and New Environmental Graphics
Omaha-based Fusion was awarded for two large marketing projects that were unveiled in late 2023.OMAHA, NE / ACCESSWIRE / March...
Year: 2024
Cipher Surgical Announces Mark Alley as Chief Executive Officer (CEO)
CHANTILLY, VA / ACCESSWIRE / March 4, 2024 / Cipher Surgical, a leading innovator in medical device technology, is pleased...
First Health Advisory Adds Health IT Leader David Finn to Deepen Digital Health Cyber Governance
Former CIO and CHIME leader David Finn joins First Health Advisory to support clients with policy changes facing the healthcare...
Neptune Announces Michael Cammarata’s Resignation Effective February 23, 2024
LAVAL, QC / ACCESSWIRE / March 4, 2024 / Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (NASDAQ:NEPT), today announced...
PharmaCord Announces Key Operational Appointments in Preparation for Its Next Phase of Growth
JEFFERSONVILLE, IN / ACCESSWIRE / March 4, 2024 / PharmaCord, a leading provider of patient services and commercialization solutions to...
Registration Is Now Open for Tribe Public’s Webinar Event “Revolutionizing Diabetes Care” Featuring Modular Medical CEO on Wednesday, March 6, 2024
Meet with Modular Medical CEO, Jeb BesserThere are more than 3 million individuals who use daily insulin to help with...
Ankle & Foot Centers of America Welcomes Dr. Cameron Neilson in Loganville, GA
Leading Podiatrist, Cameron Neilson, DPM, joins the Ankle & Foot Centers of America in Loganville, GA. Dr. Neilson is among...
Avant Brands Strengthens Board with the Addition of Tyson Macdonald
KELOWNA, BC / ACCESSWIRE / March 4, 2024 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading producer...
Prescription Transdermal Patch Abuse and Accidental Pediatric Exposure Remains a Serious Problem in the United States – Surveillance Data to Be Presented at 2024 American Academy of Pain Medicine Annual Meeting
ORLANDO, FL / ACCESSWIRE / March 4, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of prescription...
Intelligent Scopes Launches Helga AI-GEP™, an AI Platform for Gastroenterology with the Commencement of Validation of its AI Software Tool for Colon Cancer
NEW YORK and LONDON, March 04, 2024 (GLOBE NEWSWIRE) -- Intelligent Scopes Corp, specializing in state-of-the-art image enhancement and precision...
Fortress Biotech and Cyprium Therapeutics Announce $4.1 Million Grant from NINDS to Further Development of AAV-ATP7A Gene Therapy for Menkes Disease
Encouraging preclinical studies demonstrate potential to combine AAV-ATP7A gene therapy with CUTX-101, which could be the first FDA-approved treatment for...
Vaxcyte Completes Enrollment of Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease (IPD) in Infants
-- Company Expects to Announce Topline Safety, Tolerability and Immunogenicity Data from Primary Immunization Series by the End of the...
Entera Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement
JERUSALEM, March 04, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the...
NEXGEL to Present at the iAccess Alpha Best Ideas Spring Virtual Conference on March 12th
LANGHORNE, Pa., March 04, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of...
GRI Bio Receives MHRA Authorization to Conduct Phase 2a Biomarker Study Evaluating GRI-0621 in the United Kingdom
MHRA authorization expands ongoing U.S. Phase 2a biomarker study evaluating lead program GRI-0621 for the treatment of Idiopathic Pulmonary Fibrosis...
Sofwave Medical to Present Pure Impact™ Strength and Muscle Toning Module’s First U.S. Industry Reveal at the 2024 American Academy of Dermatology (AAD) Annual Meeting
SAN CLEMENTE, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in...
Ascendis Pharma to Participate in the Leerink Partners Global Biopharma Conference 2024
COPENHAGEN, Denmark, March 04, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that company executives will participate...
Safety Shot Appoints Serial Entrepreneur John Gulyas as Chairman of the Board
With multiple 7-figure exits, John Gulyas will help lead Safety Shot in its ongoing efforts to become a leading wellness...
Invitation to Participate in STOP-PC Clinical Trial
AGOURA HILLS, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) invites participation in our STOP-PC clinical trial...
Molecular Templates, Inc. Provides Interim Update
Monotherapy activity with PD-L1-targeting MT-6402 in Head and Neck Cancer; Unique pharmacodynamic effects with CTLA-4 targeting MT-8421 in on-going phase...